Under construction – not a live service
Sign in

NCT07924540Completed

Endoscopic Ultrasound Shear Wave Elastography in Solid Pancreatic Lesions

Diagnostic Accuracy of Endoscopic Ultrasound-Guided Shear Wave Elastography (EUS-SWE) in Solid Pancreatic Lesions: A Prospective Single-Center Study

Source: ClinicalTrials.gov · Last updated 9 Nov 2026

Next steps

Brief summary (registry, in English)

The aim of this prospective study is to evaluate the diagnostic accuracy of endoscopic ultrasound-guided shear wave elastography (EUS-SWE) in patients with solid pancreatic lesions. During a clinically indicated EUS with fine-needle biopsy, tissue stiffness will be measured by shear wave elastography in the pancreatic lesion and in the adjacent normal pancreatic parenchyma. Elastography values will be compared with the final cytological/histological diagnosis in order to assess the ability of EUS-SWE to differentiate malignant from benign lesions and to correlate stiffness with histological findings.

Status (registry)
Completed
Study type
Interventional
Enrollment
62 (actual)
First submitted
3 Nov 2026
Start date
1 Feb 2025
Primary completion date
1 May 2025
Lead sponsor
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
NCT number
NCT07924540

What you commit to

  • Study type: Interventional
  • Participants enrolled: 62
  • From 1 Feb 2025 to the primary completion date, 1 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Anticoagulant/antiplatelet therapy that cannot be interrupted

Lab values

  • Coagulation disorders: INR > 1.5 or platelet count < 50,000/mm3

Other

  • Lesion not identified during EUS
  • Pregnancy
  • Refusal to sign informed consent
  • Contraindication to endoscopy
  • Contraindication to sedation

Who the study is looking for

  • Age 18-85 years
  • Solid pancreatic lesion confirmed or suspected on transabdominal ultrasound, CT or MRI
  • Signed informed consent

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Regional Institute of Gastroenterology and Hepatology "Prof. Dr. Octavian Fodor"Cluj-NapocaRomaniaUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.